Mechanism: Oxidative damage to lysosomal TRPML1 causes Ca2+ leak, activating calcineurin which sequesters TFEB, leading to mTORC1 activation and suppressed autophagy. Readout: Readout: ML-SA1 treatment restores lysosomal Ca2+, activates TFEB, and enhances autophagy flux, correlating with a +25% lifespan boost.
Hypothesis
Aging triggers oxidative modification of the lysosomal Ca2+ channel TRPML1, causing a chronic luminal Ca2+ leak that activates calcineurin. Calcineurin dephosphorylates TFEB, trapping it in the cytoplasm and preventing lysosomal biogenesis. The resulting lysosomal deficit feeds back to sustain mTORC1 activation on the lysosomal surface, which keeps ULK1 inhibited and blocks autophagosome initiation. This creates a self‑reinforcing loop that actively suppresses autophagy, independent of transcriptional epigenetic clocks. Restoring TRPML1‑mediated Ca2+ flux should re‑phosphorylate TFEB, revive lysosomal function, and unlock autophagy flux before any measurable shift in methylation‑age biomarkers.
Why This Fits the Active‑Suppression Model
The seed idea proposes that autophagy is not passively broken but actively held in a "growth mode" state. mTORC1‑ULK1 inhibition and declining AMPK are noted, yet the upstream lysosomal signal that sets mTORC1 activity is rarely addressed. Lysosomal Ca2+ is a master regulator of mTORC1: low luminal Ca2+ permits mTORC1 recruitment and activation, while high Ca2+ promotes its dissociation. In senescent cells, persistent mTORC1 signaling under starvation suggests a lysosomal sensing defect. Oxidative stress, known to rise with age, can form disulfide bonds in TRPML1, altering its gating. Evidence shows oxidative crosslinking can inhibit channel activity (see ATG7‑ATG3 disulfide example). Thus, an age‑dependent TRPML1 leak provides a concrete molecular brake that aligns with Rubicon‑ and p300‑mediated VPS34 inhibition and explains why simply boosting WIPI2B or supplying young plasma can rescue autophagy—they bypass the lysosomal checkpoint.
Novel Mechanistic Insight
- Oxidative TRPML1 Modification – Cys residues in the TRPML1 pore domain form age‑dependent disulfides, shifting the channel toward a leaky, low‑conductance state. This reduces luminal Ca2+ storage without completely abolishing channel activity, creating a sustained sub‑threshold Ca2+ efflux.
- Calcineurin‑TFEB Axis – Cytosolic Ca2+ spikes activate the phosphatase calcineurin, which dephosphorylates TFEB at Ser142 and Ser138, promoting its nuclear export. Cytoplasmic TFEB fails to drive lysosomal biogenesis genes (LAMP1, CTSD), shrinking the lysosomal pool.
- Feedback to mTORC1 – Fewer, less acidic lysosomes diminish Rag‑GTPase activation, paradoxically increasing mTORC1 residence on the organelle surface. Persistent mTORC1 phosphorylates ULK1‑Ser757, blocking autophagy initiation.
- Epigenetic Clock Independence – Because the block sits at the organelle level, resetting DNA methylation (e.g., via partial reprogramming) may not immediately restore autophagy; lysosomal repair must precede epigenetic rejuvenation for functional recovery.
Testable Predictions
- Prediction 1: Aged mouse tissues will show increased TRPML1‑dependent lysosomal Ca2+ leak measured by LysoSensor fluorescence, reversible by the TRPML1 agonist ML‑SA1.
- Prediction 2: ML‑SA1 treatment will increase lysosomal Ca2+, promote TFEB phosphorylation (Ser142), boost LAMP1/CTSD expression, and enhance LC3‑II turnover—all without altering DNA‑methylation age as gauged by Horvath’s clock.
- Prediction 3: Genetic knock‑in of a cysteine‑to‑serine TRPML1 mutant (oxidation‑resistant) in aged mice will rescue autophagy flux and improve stress resistance, whereas a phospho‑dead TFEB mutant will block the rescue despite ML‑SA1.
- Prediction 4: In vitro, exposing young lymphocytes to H2O2 will mimic the aged TRPML1 leak phenotype; pretreatment with a thiol‑reducing agent (DTT) will prevent the leak and maintain autophagic flux.
Experimental Outline
- Measure lysosomal Ca2+ in liver and brain lysates from young (3 mo) vs aged (24 mo) mice using LysoSensor Yellow/Blue DND‑160; confirm increase with age and reduction with ML‑SA1.
- Assess TRPML1 oxidation via biotin‑switch assay followed by Western blot for TRPML1; compare oxidation levels across ages.
- Track TFEB localization by immunofluorescence and subcellular fractionation; quantify nuclear/cytoplasmic ratio before and after ML‑SA1.
- Read autophagy flux with bafilomycin A1‑chase and LC3‑II/p62 immunoblotting; correlate with lysosomal Ca2+ and TFEB status.
- Epigenetic clock assay using pyrosequencing of CpG sites from the same samples to verify that methylation age remains unchanged during acute lysosomal rescue.
- Genetic validation using CRISPR‑knock‑in of TRPML1‑C/S and TFEB‑S142A/S138A alleles in aged mice; repeat steps 1‑5.
Falsifiability
If lysosomal Ca2+ leak does not increase with age, or if ML‑SA1 fails to restore TFEB phosphorylation and autophagy flux despite normalizing lysosomal Ca2+, the hypothesis is refuted. Likewise, if autophagy rescue coincides with immediate methylation‑age reversal, suggesting epigenetic drift is the primary driver, the proposed organelle‑centric mechanism would be insufficient.
Implications
Positioning lysosomal Ca2+ dysregulation as the nexus of mTORC1‑ULK1 inhibition, TFEB sequestration, and autophagic suppression offers a tractable target: small‑molecule TRPML1 activators or antioxidants that prevent TRPML1 oxidation could rejuvenate cellular clearance without requiring full epigenetic reprogramming. This reframes the aged cell’s "hoarding" not as a fear of emptiness but as a mis‑sensed lysosomal environment that keeps growth signals ON, and it suggests that measuring lysosomal Ca2+ flux could serve as an early, mechanistic biomarker for interventions aimed at restoring autophagy in aging.
Comments
Sign in to comment.